1921
Volume 75, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

From 2000 to 2005, we investigated prospectively 98 cases of imported non– malaria (48 , 34 , and 16 ). Latency period between return and clinical attack exceeded three months in 40% of the patients. It was longer in travelers who had taken chemoprophylaxis. Time to diagnosis was longer in patients with infection and in those with late-onset first attack. Parasite density was often lower than 500/μL, especially in malaria. Relapses were diagnosed in 18% of all malaria episodes. Eight (17%) and 2 (6%) malaria episodes were due to relapse despite standard primaquine therapy. Diagnosis of imported non-falciparum malaria is often challenged by long latency period and low parasite density. In addition, the substantial relapse rate despite standard primaquine therapy supports the use of a higher dose of primaquine to eradicate and malaria effectively.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.75.133
2006-07-01
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/75/1/0750133.html?itemId=/content/journals/10.4269/ajtmh.2006.75.133&mimeType=html&fmt=ahah

References

  1. Kain KC, Keystone JS, 1998. Malaria in travelers. Epidemiology, disease, and prevention. Infect Dis Clin North Am 12 : 267–284.
  2. Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Nguyen-Dinh P, Roberts JM, Mali S, Parise ME, Barber AM, Steketee R, 2005. Malaria surveillance–United States, 2003. MMWR Surveill Summ 54 : 25–40.
  3. Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, Matteelli A, Clerinx J, Corachan M, Puente S, Gjorup I, Harms G, Kollaritsch H, Kotlowski A, Bjorkmann A, Delmont JP, Knobloch J, Nielsen LN, Cuadros J, Hatz C, Beran J, Schmid ML, Schulze M, Lopez-Velez R, Fleischer K, Kapaun A, McWhinney P, Kern P, Atougia J, Fry G, da Cunha S, Boecken G, 2002. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 34 : 572–576.
  4. Robinson P, Jenney AW, Tachado M, Yung A, Manitta J, Taylor K, Biggs BA, 2001. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med 8 : 76–81.
  5. Leder K, Black J, O’Brien D, Greenwood Z, Kain KC, Schwartz E, Brown G, Torresi J, 2004. Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis 39 : 1104–1112.
  6. Muhlberger N, Jelinek T, Gascon J, Probst M, Zoller T, Schunk M, Beran J, Gjorup I, Behrens RH, Clerinx J, Bjorkman A, McWhinney P, Matteelli A, Lopez-Velez R, Bisoffi Z, Hellgren U, Puente S, Schmid ML, Myrvang B, Holthoff-Stich ML, Laferl H, Hatz C, Kollaritsch H, Kapaun A, Knobloch J, Iversen J, Kotlowski A, Malvy DJ, Kern P, Fry G, Siikamaki H, Schulze MH, Soula G, Paul M, Prat J, Lehmann V, Bouchaud O, da Cunha S, Atouguia J, Boecken G, 2004. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 3 : 5.
  7. Schwartz E, Parise M, Kozarsky P, Cetron M, 2003. Delayed onset of malaria: implications for chemoprophylaxis in travelers. N Engl J Med 349 : 1510–1516.
  8. Milne LM, Kyi MS, Chiodini PL, Warhurst DC, 1994. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol 47 : 740–742.
  9. Moody A, Hunt-Cooke A, Gabbett E, Chiodini P, 2000. Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London. Br J Haematol 109 : 891–894.
  10. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39 : 1336–1345.
  11. Schwartz E, Regev-Yochay G, Kurnik D, 2000. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 62 : 393–395.
  12. Warrell DA, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 : 1–90.
  13. Elliott JH, O’Brien D, Leder K, Kitchener S, Schwartz E, Weld L, Brown GV, Kain KC, Torresi J, 2004. Imported Plasmodium vivax malaria: demographic and clinical features in non-immune travelers. J Travel Med 11 : 213–217.
  14. Bigaillon C, Fontan E, Cavallo JD, Hernandez E, Spiegel A, 2005. Ineffectiveness of the Binax NOW malaria test for diagnosis of Plasmodium ovale malaria. J Clin Microbiol 43 : 1011.
  15. Grobusch MP, Hanscheid T, Zoller T, Jelinek T, Burchard GD, 2002. Rapid immunochromatographic malarial antigen detection unreliable for detecting Plasmodium malariae and Plasmodium ovale. Eur J Clin Microbiol Infect Dis 21 : 818–820.
  16. Marx A, Pewsner D, Egger M, Nuesch R, Bucher HC, Genton B, Hatz C, Juni P, 2005. Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas. Ann Intern Med 142 : 836–846.
  17. Rougemont M, van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, 2004. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42 : 5636–5643.
  18. Maguire JD, Sumawinata IW, Masbar S, Laksana B, Prodjo-dipuro P, Susanti I, Sismadi P, Mahmud N, Bangs MJ, Baird JK, 2002. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 360 : 58–60.
  19. Singh K, Wester WC, Trenholme GM, 2003. Problems in the therapy for imported malaria in the United States. Arch Intern Med 163 : 2027–2030.
  20. Doherty JF, Day JH, Warhurst DC, Chiodini PL, 1997. Treatment of Plasmodium vivax malaria–time for a change? Trans R Soc Trop Med Hyg 91 : 76.
  21. Jelinek T, Nothdurft HD, von Sonnenburg F, Loscher T, 1995. Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Am J Trop Med Hyg 52 : 322–324.
  22. Centers for Disease Control and Prevention, 2005. Treatment for malaria: guidelines for clinicians, part 2-general approach and uncomplicated malaria. Available from http://www.cdc.gov/malaria/diagnosis_treatment/clinicians2.htm.
  23. Nathwani D, Currie PF, Smith CC, Khaund R, 1991. Recurrent plasmodium ovale infection from Papua New Guinea: chloro-quine resistance or inadequate primaquine therapy? J Infect 23 : 343–344.
  24. Rombo L, Edwards G, Ward SA, Eriksson G, Lindquist L, Lindberg A, Runehagen A, Bjorkman A, Hylander NO, 1987. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol 38 : 49–50.
  25. Bottieau E, van Gompel A, Peetermans WE, 2005. Failure of primaquine therapy for the treatment of Plasmodium ovale malaria. Clin Infect Dis 41 : 1544–1545.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.75.133
Loading
/content/journals/10.4269/ajtmh.2006.75.133
Loading

Data & Media loading...

  • Received : 08 Nov 2005
  • Accepted : 23 Feb 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error